Influence of Intravenous Ferric Carboxymaltose on Health-Related Quality of Life Measures in Patients with Chronic Heart Failure and Iron Deficiency: an Analysis from the FAIR-HF Study

被引：0
|
作者：
Comin-Colet, Josep
Lainscak, Mitja
Dickstein, Kenneth
Filippatos, Gerasimos
Johnson, Patrick
Luescher, Thomas
Mori, Claudio
Willenheimer, Ronnie
Ponikowski, Piotr
Anker, Stefan D.
机构：
[1] Hosp Mar IMAS, Barcelona, Spain
[2] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia
[3] Stavanger Univ Hosp, Stavanger, Norway
[4] Athens Univ Hosp Attikon, Athens, Greece
[5] Vifor Pharma, Glattbrug, Switzerland
[6] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[7] Lund Univ, Malmo, Sweden
[8] Clin Mil Hosp, Wroclaw, Poland
[9] Charite Campus Virchow Klinikum, Berlin, Germany
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Heart failure; Quality of life; Disease management; Energy metabolism; Hemoglobin;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A19027
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
    van Veldhuisen, Dirk J.
    Ponikowski, Piotr
    van der Meer, Peter
    Metra, Marco
    Bohm, Michael
    Doletsky, Artem
    Voors, Adriaan A.
    Macdougall, Iain C.
    Anker, Stefan D.
    Roubert, Bernard
    Zakin, Lorraine
    Cohen-Solal, Alain
    CIRCULATION, 2017, 136 (15) : 1374 - +
  • [22] Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study
    Capone, Federico
    Cipriani, Alberto
    Molinari, Leonardo
    Noale, Marianna
    Gusella, Beatrice
    Lucente, Fabrizio
    Savino, Sandro
    Bertomoro, Antonella
    Saller, Alois
    Giannini, Sandro
    Vettor, Roberto
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (08):
  • [23] A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain
    Comin-Colet, Josep
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    Enjuanes-Grau, Cristina
    Gutzwiller, Florian S.
    Anker, Stefan D.
    Ponikowski, Piotr
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (10): : 846 - 851
  • [24] Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients
    Taha, Amira Mohamed
    Elsaeidy, Ahmed Saad
    Nada, Sarah A.
    Sharma, Sadish
    Ghonaim, Mohamed M.
    Ahsan, Areeba
    Mourid, Marina Ramzy
    Abouelmagd, Khaled
    CLINICAL DRUG INVESTIGATION, 2024, 44 (12) : 879 - 896
  • [25] Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure
    Anker, Stefan D.
    Friede, Tim
    Butler, Javed
    Talha, Khawaja M.
    Diek, Monika
    Nosko, Anna
    Placzek, Marius
    Hasenfuss, Gerd
    Ponikowski, Piotr
    Karakas, Mahir
    EUROPEAN JOURNAL OF HEART FAILURE, 2025,
  • [26] Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain
    Delgado, Juan F.
    Oliva, Juan
    Gonzalez-Franco, Alvaro
    Cepeda, Jose Maria
    Garcia-Garcia, Jose Angel
    Gonzalez-Dominguez, Almudena
    Garcia-Casanovas, Albert
    Jimenez Merino, Silvia
    Comin-Colet, Josep
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (12) : 1418 - 1424
  • [27] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN AUSTRIA
    Walter, E.
    Bauer, M.
    Ressl, S.
    VALUE IN HEALTH, 2015, 18 (07) : A392 - A392
  • [28] Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
    Comin-Colet, Josep
    Enjuanes, Cristina
    Gonzalez, Gina
    Torrens, Ainhoa
    Cladellas, Merce
    Merono, Oona
    Ribas, Nuria
    Ruiz, Sonia
    Gomez, Miquel
    Maria Verdu, Jose
    Bruguera, Jordi
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1164 - 1172
  • [29] Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless the anaemia status
    Enjuanes Grau, C.
    Comin-Colet, J.
    Torrens-Oses, A.
    Gonzalez-Robledo, G.
    Cladellas, M.
    Verdu Rotellar, J. M.
    Ruiz, S.
    Bruguera-Cortada, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 489 - 489
  • [30] HEALTH CARE COST FOR PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY / ANEMIA BEFORE AND AFTER TREATMENT WITH FERRIC CARBOXYMALTOSE
    Kohls, M.
    Hardt, T.
    Barck, I
    Schultheiss, J.
    Heidler, T.
    Deiters, B.
    VALUE IN HEALTH, 2019, 22 : S554 - S554
12345